Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
Publication/Presentation Date
1-1-2022
Abstract
[This corrects the article DOI: 10.1093/noajnl/vdab153.].
Volume
4
Issue
1
First Page
011
Last Page
011
ISSN
2632-2498
Published In/Presented At
Song, A. J., Ding, K., Alnahhas, I., Laperriere, N. J., Perry, J., Mason, W. P., Winch, C., O'Callaghan, C. J., Menten, J. J., Brandes, A. A., Phillips, C., Fay, M. F., Nishikawa, R., Osoba, D., Cairncross, J. G., Roa, W., Wick, W., & Shi, W. (2022). Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial. Neuro-oncology advances, 4(1), vdac011. https://doi.org/10.1093/noajnl/vdac011
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
35098127
Department(s)
Administration and Leadership
Document Type
Article